ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19
Abstract A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide and become pandemic with thousands new deaths and infected cases globally. To address coronavirus disease (COVID-19), currently no effective drug or vaccine is available. This necessity motivate...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/56fdadd47ce44b4b95f39f40b4b20e7f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|